Side Step-Wise Development: Sponsors Aren’t Using FDA’s Preferred Approach To Biosimilars

 
• By Derrick Gingery
Steps
The approach is not working from a 'chronological' standpoint, Sarah Yim said. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics